The reduction in price target is minor, suggesting a small adjustment rather than a significant change in the company's outlook. The maintenance of a Buy rating indicates a continued positive view on the stock by UBS. This news is likely to have a neutral to slightly positive impact on Corteva's stock in the short term as the endorsement of the stock remains but with a slightly lower expected future price.